Evalúan la quimioterapia con vinblastina, bleomicina y metotrexato en el linfoma de Hodgkin
Salud(i)ciencia (Impresa); 14 (4), 2006
Background: VBM chemotherapy (vinblastine, bleomycin and methotrexate) plus irradiation is an effective therapeutic combination in early-stage Hodgkin’s lymphoma, but conflicting results have been collected on the toxicity of and correct indication for this combination. Patients and methods: The GISL t...